The potential of stem cells: An inventory;Das Potenzial von Stammzellen: Eine Bestandsaufnahme

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 47, Issue 6, 2004, Pages 565-577

  Scholer H R ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CLONING; DNA DAMAGE; EMBRYO RESEARCH; FEMALE; GENE TRANSFER; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; MULTIPOTENT STEM CELL; POINT MUTATION; PREGNANCY; REVIEW; STEM CELL TRANSPLANTATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CLONING, ORGANISM; DNA DAMAGE; EMBRYO RESEARCH; FEMALE; GENE TRANSFER TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; MICE; MULTIPOTENT STEM CELLS; POINT MUTATION; PREGNANCY; STEM CELL TRANSPLANTATION;

EID: 4444294736     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-004-0818-3     Document Type: Article

References (66)

1. Kirschstein R, Skirboll LR (2001) Stem cells: scientific progress and future directions. National Institute of Health, NIH, Bethesda
2. Till JE, McCulloch EA (1961) A direct measurement of radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213-222
3. Watt FM, Hogan BL (2000) Out of Eden: stem cells and their niches. Science 287:1427-1430
4. Aboody KS et al.(2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97:12846-12851
5. Noble M (2000) Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? Proc Natl Acad Sci USA 97:12393-12395
6. Noble M (2000) Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors? Nat Med 6:369-370
7. Boiani M, Schöler HR (2002) Determinants of pluripotency in mammals. In: Lanza R, Cibelli J, West M (eds) Principles of cloning. Academic Press, San Diego
8. Mezey E et al.(2000) Turning blood into brain: cells bearing neural antigens generated in vivo from bone marrow. Science 290:1779-1782
9. Bjornson CR et al.(1999) Turning brain into blood: a hematopoetic fate adopted by adult neural stem cells in vivo. Science 283:534-537
10. Clarke DL et al.(2000) Generalized potential of adult neural stem cells. Science 288:1660-1663
11. Lagasse E et al.(2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6:1229-1234
12. Taniguchi H et al.(1996) Presence of hemato-poietic stem cells in the adult liver. Nat Med 2:198-203
13. Theise ND et al. (2000) Liver from bone marrow in humans. Hepatology 32:11-16
14. Gussoni E et al. (1999) Dystrophin expression in the mdx mouse restored by stem cell trans-plantation. Nature 401:390-394
15. Jackson KA et al. (2001) Regeneration of ische-mic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402
16. Krause DS et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-377
17. McKinney-Freeman SL et al.(2002) Muscle-derived hematopoietic stem cells are hemato-poietic in origin. Proc Natl Acad Sci USA 99:1341-1346
18. Morshead CM et al. (2002) Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigene-tic alterations. Nat Med 8:268-273
19. Ying QL et al.(2002) Changing potency by spontaneous fusion. Nature 416:545-548
20. Terada N et al.(2002) Bone marrow cells adopt the phenotype of other cells by spontanous cell fusion. Nature 416:542-545
21. Tsai RY, Kittappa R, McKay RD (2002) Plasticity, niches, and the use of stem cells. Dev Cell 2:707-712
22. Holden C, Vogel G (2002) Plasticity: Time for a reappraisal? Science 296:2126-2129
23. D'Amour KA, Gage FH (2002) Are somatic stem cells pluripotent or lineage-restricted? Nat Med 8:213-214
24. Jiang Y et al.(2002) Pluripotency of mesenchy-mal stem cells derived from adult marrow. Nature 418:41-49
25. Jiang Y et al. (2002) Multipotent progenitor cells can be isolated from postnatal murine bone mar-row, muscle, and brain. Exp Hematol 30:896-904
26. Geiger H, Van Zant G (2002) The aging of lympho-hematopoietic stem cells. Nat Immunol 3:329-333
27. Turker MS (2000) Somatic cell mutations: can they provide a link between aging and cancer? Mech Ageing Dev 117:1-19
28. Negrin RS et al. (2000) Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 6:262-271
29. Sanchez-Ramos JR (2002) Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 69:880-893
30. Laughlin MJ et al.(2001) Hematopoietic en-graftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815-1822
31. Barker JN et al. (2002) Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8:257-260
32. Whetton AD, Graham GJ (1999) Homing and mobilization in the stem cell niche. Trends Cell Biol 9:233-238
33. Spradling A, Drummond-Barbosa D, Kai T (2001) Stem cells find their niche. Nature 414:98-104
34. Wobus AM et al. (2002) Embryonic stem cells as a model to study cardiac, skeletal muscle, and vascular smooth muscle cell differentiation. Methods Mol Biol 185:127-156
35. Thomson JA et al. (1998) Embryonic stem cell lines derived from human blastocystes. Science 282:1145-1147
36. Kim JH et al.(2002) Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56
37. McDonald JW et al.(1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5:1410-1413
38. Lumelsky N et al. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292:1389-1394
39. Richards M et al. (2002) Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20:933-936
40. Nichols J, Evans EP, Smith AG (1990) Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110:1341-1348
41. Odorico JS, Kaufman DS, Thomson JA (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193-204
42. Kunkel TA (1999) The high cost of living. Trends Genet 15:93-94
43. Kunkel TA, Bebenek K (2000) DNA replication fidelity. Annu Rev Biochem 69:497-529
44. Fandrich F et al.(2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171-178
45. Woods NB, Ooka A, Karlsson S (2002) Development of gene therapy for hematopoietic stem cells using lentiviral vectors. Leukemia 16, 563-569
46. Wakayama T et al.(2001) Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292:740-743
47. Munsie MJ et al. (2000) Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol 10:989-992
48. Boiani M et al. (2002) Oct4 distribution and level in mouse clones: consequences for pluripotency. Genes Dev 16:1209-1219
49. Pesce M, Schöler HR (2000) Oct-4: Control of totipotency and germline determination. Mol Reprod Dev 55:452-457
50. Pesce M, Schöler HR (2001) Oct-4: Gatekeeper in the beginnings of mammalian development. Stem Cells 19:271-276
51. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376
52. Yoshimizu T et al.(1999) Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ 41:675-684
53. Yeom YL et al. (1996) Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122:881-894
54. Hübner R et al. (2003) Derivation of oocytes form mouse embryonic stem cells. Science 300:1251-1256
55. Wilmut I et al. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385:810-813
56. Antonarakis SE, Krawczak M, Cooper DN (2000) Disease-causing mutations in the human ge-nome. Eur J Pediatr 159 [Suppl 3]:173-178
57. Mori H et al.(2002) Chromosome translocation and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 99:8242-8247
58. Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362:709-715
59. Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151-155
60. Svejstrup JQ (2002) Transcription repair coupling factor: a very pushy enzyme. Mol Cell 9:1151-1152
61. Guarente L, Kenyon C (2000) Genetic pathways that regulate ageing in model organisms. Nature 408:255-262
62. Sharpless NE, DePinho RA (2002) P53: good cop/bad cop. Cell 110:9-12
63. Hahn WC, Weinberg RA (2002) Modeling the molecular circuitry of cancer. Nat Rev Cancer 2:331-341
64. Li E (2002) Chromatin modification and epige-netic reprogramming in mammalian develop-ment. Nat Rev Genet 3:662-673
65. Humpherys D et al.(2002) Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci USA 99:12889-12894
66. Tamashiro KL et al.(2002) Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med 8:262-267